Recombinant multi-species CEP57 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CEP57 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a cytoplasmic protein called Translokin. This protein localizes to the centrosome and has a function in microtubular stabilization. The N-terminal half of this protein is required for its centrosome localization and for its multimerization, and the C-terminal half is required for nucleating, bundling and anchoring microtubules to the centrosomes. This protein specifically interacts with fibroblast growth factor 2 (FGF2), sorting nexin 6, Ran-binding protein M and the kinesins KIF3A and KIF3B, and thus mediates the nuclear translocation and mitogenic activity of the FGF2. It also interacts with cyclin D1 and controls nucleocytoplasmic distribution of the cyclin D1 in quiescent cells. This protein is crucial for maintaining correct chromosomal number during cell division. Mutations in this gene cause mosaic variegated aneuploidy syndrome, a rare autosomal recessive disorder. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2011]
The Alternative Names of target: 3110002L15Rik,3110002l15rik,4921510P06Rik,4931428M20Rik,CEP57,Centrosomal protein of 57 kDa,Cep57,FGF2-interacting protein,MVA2,PIG8,RGD1309884,TSP57,Testis-specific protein 57,Translokin,Tsp57,mKIAA0092
Go
to CEP57 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1572-Ag-1/ GM-Tg-hg-SE1572-Ag-2 | Human CEP57 protein | Human |
| GM-Tg-rg-SE1572-Ag-1/ GM-Tg-rg-SE1572-Ag-2 | Rat CEP57 protein | Rat |
| GM-Tg-mg-SE1572-Ag-1/ GM-Tg-mg-SE1572-Ag-2 | Mouse CEP57 protein | Mouse |
| GM-Tg-cynog-SE1572-Ag-1/ GM-Tg-cynog-SE1572-Ag-2 | Cynomolgus/Rhesus macaque CEP57 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1572-Ag-1/ GM-Tg-felg-SE1572-Ag-2 | Feline CEP57 protein | Feline |
| GM-Tg-cang-SE1572-Ag-1/ GM-Tg-cang-SE1572-Ag-2 | Canine CEP57 protein | Canine |
| GM-Tg-bovg-SE1572-Ag-1/ GM-Tg-bovg-SE1572-Ag-2 | Bovine CEP57 protein | Bovine |
| GM-Tg-equg-SE1572-Ag-1/ GM-Tg-equg-SE1572-Ag-2 | Equine CEP57 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE1572-Ag-1/ GM-Tg-hg-SE1572-Ag-2;
GM-Tg-rg-SE1572-Ag-1/ GM-Tg-rg-SE1572-Ag-2;
GM-Tg-mg-SE1572-Ag-1/ GM-Tg-mg-SE1572-Ag-2; GM-Tg-cynog-SE1572-Ag-1/ GM-Tg-cynog-SE1572-Ag-2; GM-Tg-felg-SE1572-Ag-1/ GM-Tg-felg-SE1572-Ag-2; GM-Tg-cang-SE1572-Ag-1/ GM-Tg-cang-SE1572-Ag-2; GM-Tg-bovg-SE1572-Ag-1/ GM-Tg-bovg-SE1572-Ag-2; GM-Tg-equg-SE1572-Ag-1/ GM-Tg-equg-SE1572-Ag-2 |
| Products Name | CEP57 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CEP57 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CEP57 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.